Rituximab in treatment of Relapsing Multiple Sclerosis: Experience from a single center in North India

被引:0
|
作者
Khurana, D. [1 ]
Kaur, G. [2 ]
Kumar, A. [3 ]
机构
[1] Postgrad Inst Med Educ & Res, Neurol, Chandigarh, India
[2] Postgrad Inst Med Educ & Res PGIMER, Neurol, Chandigarh, India
[3] Postgrad Inst Med Educ & Res, Nursing, Chandigarh, India
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P343
引用
收藏
页码:177 / 177
页数:1
相关论文
共 50 条
  • [31] MS Center Experience of Use of Rituximab in Secondary-Progressive Multiple Sclerosis
    Ionete, Carolina
    Beretich, Biliana
    Riskind, Peter
    NEUROLOGY, 2009, 72 (11) : A318 - A318
  • [32] Rituximab treatment for multiple sclerosis
    Ineichen, Benjamin V.
    Moridi, Thomas
    Granberg, Tobias
    Piehl, Fredrik
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (02) : 137 - 152
  • [33] Rituximab treatment in children with nephrotic syndrome: a single center experience
    Dursun, I.
    Kacar, P.
    Gunduz, Z.
    Dusunsel, R.
    Poyrazoglu, H.
    Sozeri, B.
    Kisaarslan, A.
    PEDIATRIC NEPHROLOGY, 2016, 31 (10) : 1847 - 1848
  • [34] Rituximab for the treatment of membranous nephropathy: a single-center experience
    Rigler, Andreja Ales
    Jerman, Alexander
    Orsag, Alesa
    Kojc, Nika
    Kovac, Damjan
    Skoberne, Andrej
    Borstnar, Spela
    Haler, Zeljka Veceric
    Avgustin, Nusa
    Kveder, Radoslav
    Ferluga, Dusan
    Vizjak, Alenka
    Lindic, Jelka
    CLINICAL NEPHROLOGY, 2017, 88 : S27 - S31
  • [35] Teriflunomide for the treatment of relapsing-remitting multiple sclerosis: the Chieti experience
    di Ioia, M.
    Travaglini, D.
    Di Tommaso, V.
    Mancinelli, L.
    Pietrolongo, E.
    De Luca, G.
    Farina, D.
    Lugaresi, A.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 754 - 754
  • [36] Real life experience with Tecfidera treatment in relapsing remitting multiple sclerosis
    Shanmugam, S. Vijayarangam
    Cousins, O.
    Wilton, J.
    Leung, Y.
    Edwards, A.
    Wren, D.
    Craner, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 403 - 404
  • [37] Rituximab following natalizumab withdrawal in relapsing remitting multiple sclerosis
    Beaber, B. E.
    Mallari, G.
    Le, D.
    Langer-Gould, A. M.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 193 - 193
  • [38] Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience
    Zecca, Chiara
    Bovis, Francesca
    Novi, Giovanni
    Capobianco, Marco
    Lanzillo, Roberta
    Frau, Jessica
    Repice, Anna Maria
    Hakiki, Bahia
    Realmuto, Sabrina
    Bonavita, Simona
    Curti, Erica
    Brambilla, Laura
    Mataluni, Giorgia
    Cavalla, Paola
    Di Sapio, Alessia
    Signoriello, Elisabetta
    Barone, Stefania
    Maniscalco, Giorgia T.
    Maietta, Ilaria
    Maraffi, Isabella
    Boffa, Giacomo
    Malucchi, Simona
    Nozzolillo, Agostino
    Coghe, Giancarlo
    Mechi, Claudia
    Salemi, Giuseppe
    Gallo, Antonio
    Sacco, Rosaria
    Cellerino, Maria
    Malentacchi, Maria
    De Angelis, Marcello
    Lorefice, Lorena
    Magnani, Eliana
    Prestipino, Elio
    Sperli, Francesca
    Morra, Vincenzo Brescia
    Fenu, Giuseppe
    Barilaro, Alessandro
    Abbadessa, Gianmarco
    Signori, Alessio
    Granella, Franco
    Amato, Maria Pia
    Uccelli, Antonio
    Gobbi, Claudio
    Sormani, Maria Pia
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (12) : 1519 - 1531
  • [39] Assessing the efficacy, tolerability, and safety of rituximab for the treatment of multiple sclerosis: experience in 313 patients at a large academic center
    Alvarez, E.
    Seibert, J.
    Vollmer, B.
    Blackburn, J.
    Strobel, M.
    Freeman, J.
    Sillau, S.
    Honce, J.
    Bennett, J. L.
    Miravalle, A.
    Schreiner, T.
    Corboy, J.
    Vollmer, T.
    Nair, K.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 544 - 544
  • [40] Fingolimod treatment in relapsing-remitting multiple sclerosis-The real-world experience at Rashid Hospital Multiple Sclerosis (MS)Center in Dubai
    Inshasi, Jihad Said
    Sarathchandran, Pournamy
    Alboudi, Ayman
    Kamal, Yasmine
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP10 - NP10